Risk Ratios of the Effect of Central Venous Catheters With or Without Impregnation on Catheter-Related Bloodstream Infection
| MNR | … | … | … | … | … | … | … | … | 0.26 (.11–.65) | … | 0.25 (.14–.48) | … |
| 0.71 (.23–2.14) | HEP | … | … | … | … | … | … | … | 1.29 (.30–5.66) | … | 0.23 (.07–.72) | … |
| 0.50 (.24–1.04) | 0.71 (.25–1.99) | SIL | … | … | … | … | … | … | … | … | 0.56 (.39–.81) | … |
| 0.47 (.16–1.37) | 0.66 (.18–2.42) | 0.93 (.34–2.54) | BZK | … | … | … | … | … | 0.78 (.33–1.81) | … | … | … |
| 0.51 (.01–27.00) | 0.73 (.01–40.80) | 1.02 (.02–52.42) | 1.10 (.02–61.15) | CFZ | … | … | … | … | … | … | … | … |
| 0.42 (.19–.92) | 0.59 (.20–1.74) | 0.84 (.41–1.69) | 0.90 (.33–2.46) | 0.82 (.02–42.75) | 5FU | … | … | … | 0.92 (.67–1.25) | … | … | … |
| 0.42 (.13–1.31) | 0.59 (.15–2.30) | 0.83 (.29–2.41) | 0.89 (.24–3.40) | 0.82 (.01–46.16) | 1.00 (.32–3.07) | SIC | … | … | … | … | 0.62 (.25–1.55) | … |
| 0.38 (.09–1.56) | 0.54 (.11–2.63) | 0.76 (.20–2.89) | 0.8 (.17–3.90) | 0.7 (.01–45.62) | 0.91 (.23–3.66) | 0.91 (.18–4.53) | TEC | … | … | … | 0.75 (.22–2.52) | … |
| 0.32 (.01–17.12) | 0.45 (.01–25.87) | 0.64 (.01–33.25) | 0.69 (.01–38.77) | 0.63 (.00–160.57) | 0.77 (.01–40.60) | 0.77 (.01–44.00) | 0.84 (.01–52.36) | MCR | … | … | … | … |
| 0.38 (.21–.71) | 0.54 (.21–1.41) | 0.77 (.46–1.27) | 0.82 (.34–1.98) | 0.75 (.01–37.96) | 0.92 (.56–1.50) | 0.92 (.33–2.52) | 1.01 (.27–3.71) | 1.20 (.02–61.50) | CSS | … | 0.73 (.57–.94) | … |
| 0.37 (.14–1.00) | 0.53 (.16–1.79) | 0.74 (.31–1.77) | 0.79 (.24–2.64) | 0.72 (.01–39.24) | 0.89 (.34–2.33) | 0.89 (.25–3.10) | 0.98 (.22–4.32) | 1.16 (.02–63.56) | 0.97 (.42–2.23) | SPC | 0.79 (.40–1.56) | … |
| 0.29 (.16–.52) | 0.41 (.16–1.04) | 0.57 (.38–.86) | 0.61 (.24–1.53) | 0.56 (.01–27.98) | 0.68 (.39–1.21) | 0.68 (.26–1.82) | 0.75 (.21–2.67) | 0.89 (.02–45.33) | 0.74 (.56–1.00) | 0.77 (.35–1.67) | NO | 0.43 (.13–1.37) |
| 0.12 (.03–0.47) | 0.17 (.04–.80) | 0.25 (.07–.87) | 0.26 (.06–1.19) | 0.24 (.00–14.43) | 0.29 (.08–1.11) | 0.29 (.06–1.38) | 0.32 (.06–1.86) | 0.38 (.01–23.36) | 0.32 (.09–1.10) | 0.33 (.08–1.38) | 0.43 (.13–1.43) | CHX |
| 89.7 | 74.9 | 62.4 | 56.8 | 53.3 | 50.8 | 50.3 | 45.8 | 45.4 | 44.3 | 44.0 | 24.0 | 8.4 |
| MNR | … | … | … | … | … | … | … | … | 0.26 (.11–.65) | … | 0.25 (.14–.48) | … |
| 0.71 (.23–2.14) | HEP | … | … | … | … | … | … | … | 1.29 (.30–5.66) | … | 0.23 (.07–.72) | … |
| 0.50 (.24–1.04) | 0.71 (.25–1.99) | SIL | … | … | … | … | … | … | … | … | 0.56 (.39–.81) | … |
| 0.47 (.16–1.37) | 0.66 (.18–2.42) | 0.93 (.34–2.54) | BZK | … | … | … | … | … | 0.78 (.33–1.81) | … | … | … |
| 0.51 (.01–27.00) | 0.73 (.01–40.80) | 1.02 (.02–52.42) | 1.10 (.02–61.15) | CFZ | … | … | … | … | … | … | … | … |
| 0.42 (.19–.92) | 0.59 (.20–1.74) | 0.84 (.41–1.69) | 0.90 (.33–2.46) | 0.82 (.02–42.75) | 5FU | … | … | … | 0.92 (.67–1.25) | … | … | … |
| 0.42 (.13–1.31) | 0.59 (.15–2.30) | 0.83 (.29–2.41) | 0.89 (.24–3.40) | 0.82 (.01–46.16) | 1.00 (.32–3.07) | SIC | … | … | … | … | 0.62 (.25–1.55) | … |
| 0.38 (.09–1.56) | 0.54 (.11–2.63) | 0.76 (.20–2.89) | 0.8 (.17–3.90) | 0.7 (.01–45.62) | 0.91 (.23–3.66) | 0.91 (.18–4.53) | TEC | … | … | … | 0.75 (.22–2.52) | … |
| 0.32 (.01–17.12) | 0.45 (.01–25.87) | 0.64 (.01–33.25) | 0.69 (.01–38.77) | 0.63 (.00–160.57) | 0.77 (.01–40.60) | 0.77 (.01–44.00) | 0.84 (.01–52.36) | MCR | … | … | … | … |
| 0.38 (.21–.71) | 0.54 (.21–1.41) | 0.77 (.46–1.27) | 0.82 (.34–1.98) | 0.75 (.01–37.96) | 0.92 (.56–1.50) | 0.92 (.33–2.52) | 1.01 (.27–3.71) | 1.20 (.02–61.50) | CSS | … | 0.73 (.57–.94) | … |
| 0.37 (.14–1.00) | 0.53 (.16–1.79) | 0.74 (.31–1.77) | 0.79 (.24–2.64) | 0.72 (.01–39.24) | 0.89 (.34–2.33) | 0.89 (.25–3.10) | 0.98 (.22–4.32) | 1.16 (.02–63.56) | 0.97 (.42–2.23) | SPC | 0.79 (.40–1.56) | … |
| 0.29 (.16–.52) | 0.41 (.16–1.04) | 0.57 (.38–.86) | 0.61 (.24–1.53) | 0.56 (.01–27.98) | 0.68 (.39–1.21) | 0.68 (.26–1.82) | 0.75 (.21–2.67) | 0.89 (.02–45.33) | 0.74 (.56–1.00) | 0.77 (.35–1.67) | NO | 0.43 (.13–1.37) |
| 0.12 (.03–0.47) | 0.17 (.04–.80) | 0.25 (.07–.87) | 0.26 (.06–1.19) | 0.24 (.00–14.43) | 0.29 (.08–1.11) | 0.29 (.06–1.38) | 0.32 (.06–1.86) | 0.38 (.01–23.36) | 0.32 (.09–1.10) | 0.33 (.08–1.38) | 0.43 (.13–1.43) | CHX |
| 89.7 | 74.9 | 62.4 | 56.8 | 53.3 | 50.8 | 50.3 | 45.8 | 45.4 | 44.3 | 44.0 | 24.0 | 8.4 |
Impregnations are ordered according to surface under the cumulative ranking curve (SUCRA). Estimates were presented as risk ratio (95% confidence interval). Results of direct comparisons were listed in the upper triangle where the estimation was calculated as the column-defining treatment compared with the row-defining treatment. Network estimates were listed in the lower triangle where the estimation was calculated as the row-defining treatment compared with the column-defining treatment. The SUCRA values are presented in the bottom row of the table. The larger the SUCRA value, the better the treatment. Significant results are shown in bold.
Abbreviations: BZK, benzalkonium; CFZ, cefazolin; CHX, chlorhexidine; CSS, chlorhexidine-silver sulfadiazine; 5FU, 5-fluorouracil; HEP, heparin; MCR, miconazole-rifampicin; MNR, minocycline-rifampicin; NO, no impregnation; SIC, silver-impregnated cuff; SIL, silver; SPC, silver-platinum-carbon; TEC, teicoplanin.
Risk Ratios of the Effect of Central Venous Catheters With or Without Impregnation on Catheter-Related Bloodstream Infection
| MNR | … | … | … | … | … | … | … | … | 0.26 (.11–.65) | … | 0.25 (.14–.48) | … |
| 0.71 (.23–2.14) | HEP | … | … | … | … | … | … | … | 1.29 (.30–5.66) | … | 0.23 (.07–.72) | … |
| 0.50 (.24–1.04) | 0.71 (.25–1.99) | SIL | … | … | … | … | … | … | … | … | 0.56 (.39–.81) | … |
| 0.47 (.16–1.37) | 0.66 (.18–2.42) | 0.93 (.34–2.54) | BZK | … | … | … | … | … | 0.78 (.33–1.81) | … | … | … |
| 0.51 (.01–27.00) | 0.73 (.01–40.80) | 1.02 (.02–52.42) | 1.10 (.02–61.15) | CFZ | … | … | … | … | … | … | … | … |
| 0.42 (.19–.92) | 0.59 (.20–1.74) | 0.84 (.41–1.69) | 0.90 (.33–2.46) | 0.82 (.02–42.75) | 5FU | … | … | … | 0.92 (.67–1.25) | … | … | … |
| 0.42 (.13–1.31) | 0.59 (.15–2.30) | 0.83 (.29–2.41) | 0.89 (.24–3.40) | 0.82 (.01–46.16) | 1.00 (.32–3.07) | SIC | … | … | … | … | 0.62 (.25–1.55) | … |
| 0.38 (.09–1.56) | 0.54 (.11–2.63) | 0.76 (.20–2.89) | 0.8 (.17–3.90) | 0.7 (.01–45.62) | 0.91 (.23–3.66) | 0.91 (.18–4.53) | TEC | … | … | … | 0.75 (.22–2.52) | … |
| 0.32 (.01–17.12) | 0.45 (.01–25.87) | 0.64 (.01–33.25) | 0.69 (.01–38.77) | 0.63 (.00–160.57) | 0.77 (.01–40.60) | 0.77 (.01–44.00) | 0.84 (.01–52.36) | MCR | … | … | … | … |
| 0.38 (.21–.71) | 0.54 (.21–1.41) | 0.77 (.46–1.27) | 0.82 (.34–1.98) | 0.75 (.01–37.96) | 0.92 (.56–1.50) | 0.92 (.33–2.52) | 1.01 (.27–3.71) | 1.20 (.02–61.50) | CSS | … | 0.73 (.57–.94) | … |
| 0.37 (.14–1.00) | 0.53 (.16–1.79) | 0.74 (.31–1.77) | 0.79 (.24–2.64) | 0.72 (.01–39.24) | 0.89 (.34–2.33) | 0.89 (.25–3.10) | 0.98 (.22–4.32) | 1.16 (.02–63.56) | 0.97 (.42–2.23) | SPC | 0.79 (.40–1.56) | … |
| 0.29 (.16–.52) | 0.41 (.16–1.04) | 0.57 (.38–.86) | 0.61 (.24–1.53) | 0.56 (.01–27.98) | 0.68 (.39–1.21) | 0.68 (.26–1.82) | 0.75 (.21–2.67) | 0.89 (.02–45.33) | 0.74 (.56–1.00) | 0.77 (.35–1.67) | NO | 0.43 (.13–1.37) |
| 0.12 (.03–0.47) | 0.17 (.04–.80) | 0.25 (.07–.87) | 0.26 (.06–1.19) | 0.24 (.00–14.43) | 0.29 (.08–1.11) | 0.29 (.06–1.38) | 0.32 (.06–1.86) | 0.38 (.01–23.36) | 0.32 (.09–1.10) | 0.33 (.08–1.38) | 0.43 (.13–1.43) | CHX |
| 89.7 | 74.9 | 62.4 | 56.8 | 53.3 | 50.8 | 50.3 | 45.8 | 45.4 | 44.3 | 44.0 | 24.0 | 8.4 |
| MNR | … | … | … | … | … | … | … | … | 0.26 (.11–.65) | … | 0.25 (.14–.48) | … |
| 0.71 (.23–2.14) | HEP | … | … | … | … | … | … | … | 1.29 (.30–5.66) | … | 0.23 (.07–.72) | … |
| 0.50 (.24–1.04) | 0.71 (.25–1.99) | SIL | … | … | … | … | … | … | … | … | 0.56 (.39–.81) | … |
| 0.47 (.16–1.37) | 0.66 (.18–2.42) | 0.93 (.34–2.54) | BZK | … | … | … | … | … | 0.78 (.33–1.81) | … | … | … |
| 0.51 (.01–27.00) | 0.73 (.01–40.80) | 1.02 (.02–52.42) | 1.10 (.02–61.15) | CFZ | … | … | … | … | … | … | … | … |
| 0.42 (.19–.92) | 0.59 (.20–1.74) | 0.84 (.41–1.69) | 0.90 (.33–2.46) | 0.82 (.02–42.75) | 5FU | … | … | … | 0.92 (.67–1.25) | … | … | … |
| 0.42 (.13–1.31) | 0.59 (.15–2.30) | 0.83 (.29–2.41) | 0.89 (.24–3.40) | 0.82 (.01–46.16) | 1.00 (.32–3.07) | SIC | … | … | … | … | 0.62 (.25–1.55) | … |
| 0.38 (.09–1.56) | 0.54 (.11–2.63) | 0.76 (.20–2.89) | 0.8 (.17–3.90) | 0.7 (.01–45.62) | 0.91 (.23–3.66) | 0.91 (.18–4.53) | TEC | … | … | … | 0.75 (.22–2.52) | … |
| 0.32 (.01–17.12) | 0.45 (.01–25.87) | 0.64 (.01–33.25) | 0.69 (.01–38.77) | 0.63 (.00–160.57) | 0.77 (.01–40.60) | 0.77 (.01–44.00) | 0.84 (.01–52.36) | MCR | … | … | … | … |
| 0.38 (.21–.71) | 0.54 (.21–1.41) | 0.77 (.46–1.27) | 0.82 (.34–1.98) | 0.75 (.01–37.96) | 0.92 (.56–1.50) | 0.92 (.33–2.52) | 1.01 (.27–3.71) | 1.20 (.02–61.50) | CSS | … | 0.73 (.57–.94) | … |
| 0.37 (.14–1.00) | 0.53 (.16–1.79) | 0.74 (.31–1.77) | 0.79 (.24–2.64) | 0.72 (.01–39.24) | 0.89 (.34–2.33) | 0.89 (.25–3.10) | 0.98 (.22–4.32) | 1.16 (.02–63.56) | 0.97 (.42–2.23) | SPC | 0.79 (.40–1.56) | … |
| 0.29 (.16–.52) | 0.41 (.16–1.04) | 0.57 (.38–.86) | 0.61 (.24–1.53) | 0.56 (.01–27.98) | 0.68 (.39–1.21) | 0.68 (.26–1.82) | 0.75 (.21–2.67) | 0.89 (.02–45.33) | 0.74 (.56–1.00) | 0.77 (.35–1.67) | NO | 0.43 (.13–1.37) |
| 0.12 (.03–0.47) | 0.17 (.04–.80) | 0.25 (.07–.87) | 0.26 (.06–1.19) | 0.24 (.00–14.43) | 0.29 (.08–1.11) | 0.29 (.06–1.38) | 0.32 (.06–1.86) | 0.38 (.01–23.36) | 0.32 (.09–1.10) | 0.33 (.08–1.38) | 0.43 (.13–1.43) | CHX |
| 89.7 | 74.9 | 62.4 | 56.8 | 53.3 | 50.8 | 50.3 | 45.8 | 45.4 | 44.3 | 44.0 | 24.0 | 8.4 |
Impregnations are ordered according to surface under the cumulative ranking curve (SUCRA). Estimates were presented as risk ratio (95% confidence interval). Results of direct comparisons were listed in the upper triangle where the estimation was calculated as the column-defining treatment compared with the row-defining treatment. Network estimates were listed in the lower triangle where the estimation was calculated as the row-defining treatment compared with the column-defining treatment. The SUCRA values are presented in the bottom row of the table. The larger the SUCRA value, the better the treatment. Significant results are shown in bold.
Abbreviations: BZK, benzalkonium; CFZ, cefazolin; CHX, chlorhexidine; CSS, chlorhexidine-silver sulfadiazine; 5FU, 5-fluorouracil; HEP, heparin; MCR, miconazole-rifampicin; MNR, minocycline-rifampicin; NO, no impregnation; SIC, silver-impregnated cuff; SIL, silver; SPC, silver-platinum-carbon; TEC, teicoplanin.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
